NBIX vs RELL · P/E 45, rev $2.36B vs rev $51.9M
Neurocrine Biosciences Inc (NBIX) versus Richardson Electronics Ltd (RELL) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Richardson Electronics Ltd (RELL) is a electronic components company listed on US.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported RELL revenue for 2025-05-31 was $51.9M. Net income was -$1.1M. Revenue was down 3.6% from 2025-03-01 to 2025-05-31. RELL currently screens at market cap $141.1M.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. RELL currently screens at market cap $141.1M.
Not investment advice. Open the NBIX and RELL stock pages for the full models.
Not investment advice.